Intercure annual revenue
2019
2020
2021
2022
2023
2024
2025
Intercure Revenue Growth & History (INCR)
Intercure reported ₪270.2M in revenue for fiscal 2025, an increase of 13.13% from the previous fiscal year.
View full Intercure company overviewIntercure annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | ₪270.2M | ₪31.4M | +13.13% |
| 2024 | 2024-12-31 | ₪238.8M | −₪116.7M | −32.82% |
| 2023 | 2023-12-31 | ₪355.6M | −₪33.1M | −8.52% |
| 2022 | 2022-12-31 | ₪388.7M | ₪169.0M | +76.93% |
| 2021 | 2021-12-31 | ₪219.7M | ₪154.6M | +237.78% |
| 2020 | 2020-12-31 | ₪65.0M | ₪56.1M | +628.60% |
| 2019 | 2019-12-31 | ₪8.9M | — | — |
Intercure revenue growth trends
Over the last five reported fiscal years, revenue grew from ₪65.0M to ₪270.2M, a compound annual growth rate of 32.96%.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Intercure source filings ↗Community posts
InterCure resolves Nasdaq minimum-bid-price deficiency
InterCure ($INCR) received written confirmation that it has regained compliance with Nasdaq’s minimum-bid-price requirement. Its shares had closed at or above $1 for ten consecutive business days, allowing Nasdaq to close the specific defic ...
